abstract |
To promote apoptosis in the treatment of therapeutic agents associated with human p53 and binding to HMD2, or members of the HMD2 or HDM2 family, for example, and to members of the HMD2 or HDM2 family Cross-linked peptides that bind to useful HDM2 family members. |